BridgeBio Pharma, Inc. Common Stock

BBIONASDAQ • USD
78.30 USD
↗ 0.13 (0.17%)AT CLOSE (03:59 PM EST)
78.30
↘ 0.01 (0.01%)
POST MARKET (AS OF 04:14 PM EST)
Post Market
AS OF 04:14 PM EST
78.30
↘ 0.01 (0.01%)
🔴Market: CLOSED

BridgeBio Pharma, Inc. Common Stock (BBIO) trades at $78.30 per share. There is a divergence between signals — technical indicators rate "Strong Buy" but underlying fundamentals lean "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, exceptional Return on Equity (35.6%) and a bearish Death Cross on the long-term moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Nov 13, 2026.

Open?$78.60
High?$79.13
Low?$77.58
Prev. Close?$78.17
Volume?1.1M
Avg. Volume?2.8M
VWAP?$78.33
Rel. Volume?0.40x
Bid / Ask
Bid?$72.99 × 100
Ask?$80.30 × 100
Spread?$7.31
Midpoint?$76.65
Valuation & Ratios
Market Cap?15.3B
Shares Out?194.8M
Float?160.4M
Float %?82.0%
P/E Ratio?N/A
P/B Ratio?-9.18
EPS?-$3.04
Dividend?0.02%
Ex-Dividend?N/A
News
Profile
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. Its key drug is Attruby (acoramidis), an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
Employees
839
Market Cap
15.3B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2019-06-27
Address
3160 PORTER DR.
PALO ALTO, CA 94304
Phone: (650) 391-9740
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
3
Momentum?
98
Short Sent.?
34
Piotroski F-Score?3/9Weak
Altman Z-Score?0.16Distress
Confidence?58%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?13.00%High
Short Interest?20.8M
Days to Cover?7.1
Free Float160.4M
Avg Daily Volume3.0M
Settlement Date2026-10-30
Financial Health
Current Ratio?2.09Strong
Quick Ratio?2.03Strong
Cash Ratio?1.57Strong
Debt/Equity?-1.49Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
S&P
97
-9.18CHEAP▾
P/S?
Peers
100
S&P
3
16.13HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-46.5CHEAP▾
EV/Sales?
Peers
100
S&P
3
17.13HIGH▾
Returns & Efficiency
ROE?
Peers
50
S&P
84
35.6%STRONG▾
ROA?
S&P
3
-27.4%WEAK▾
Cash Flow & Enterprise
FCF?$-369805000
Enterprise Value?$16.2B
Fundamentals ratios updated end of day